![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3989|14|3|205-212
ISSN: 1871-5265
Source: Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.14, Iss.3, 2014-10, pp. : 205-212
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Recognition, Treatment and Complications of Meningococcal Disease
By Andrew F.
Pediatric Drugs, Vol. 1, Iss. 4, 1999-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Booster dose of serogroup C meningococcal vaccine of value
Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meningococcal serogroup C vaccination programme well worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Makris Marinos C. Polyzos Konstantinos A. Mavros Michael N. Athanasiou Stavros Rafailidis Petros I. Falagas Matthew E.
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :